M4MM

Curaleaf Reports Q3 2025 Financial Results

STAMFORD – Curaleaf Holdings Inc. unveiled its third-quarter financials, revealing a revenue figure that edged past analyst forecasts while underscoring the company's deepening reliance on global markets to counter domestic challenges. The Cannabis MSO recorded ...

Tilray Brands Reports Fiscal Q1 2026 Earnings

NEW YORK – Tilray Brands Inc. swung to a profit in its fiscal first quarter, fueled by record revenue and sharper cost management, as the Cannabis company builds on a multiyear turnaround. For the period ...

Curaleaf Reports Q3 2025 Financial Results

STAMFORD – Curaleaf Holdings Inc. unveiled its third-quarter financials, revealing a revenue figure that edged past analyst forecasts while underscoring the company's deepening reliance on global markets to counter domestic challenges. The Cannabis MSO recorded ...

Compass Pathways Advances Psilocybin Research in the UK

LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...

Ohio’s Cannabis Market Expansion in 2024

LOS ANGELES- In 2024, Ohio's legal cannabis market achieved sales exceeding $675 million, marking a 40% increase from the previous year's $484 million. This growth is attributed to the commencement of adult-use cannabis sales in ...

Kentucky Implements Medical Cannabis Program

LOS ANGELES- As of January 1, 2025, Kentucky has officially implemented its medical cannabis program, allowing residents with qualifying medical conditions to access cannabis for therapeutic purposes. This development follows the enactment of Senate Bill ...

Subscribe To Our Newsletter